Trademarkia Logo

Canada

C$
Repotrectinib Logo
ADVERTISED

on 2 Apr 2025

Last Applicant/ Owned by

Turning Point Therapeutics, Inc.

10628 Science Center Drive, Suite 200San Diego, CA 92121

US

Serial Number

2295527 filed on 28th Nov 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

Repotrectinib Logo

Trademark usage description

pharmaceutical preparations for the treatment of cancer;

Vienna Information


9 . 1 . 10

Ribbons, bowsRubans, noeuds

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 7 . 15

Triangles or lines forming an angle with one or more quadrilateralsTriangles ou lignes formant un angle avec un ou plusieurs quadrilatères

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer;


Classification kind code

12

Mark Details


Serial Number

2295527

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 2th Apr 2025
Advertised
Submitted for opposition 26
on 3rd Mar 2025
Approved
Submitted for opposition 27
on 3rd Mar 2025
Approval Notice Sent
Submitted for opposition 22
on 21st Feb 2025
Search Recorded
Submitted for opposition 287
on 6th Jun 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 28th Nov 2023
Filed
Submitted for opposition 1
on 28th Nov 2023
Created
Submitted for opposition 31
on 28th Nov 2023
Formalized